Salvage focal ablative therapy for radio-recurrent prostate cancer is safe and provides good short to medium-term oncological control

This is a press release from Sonacare Medical and PRWeb.com.   SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, is pleased to report a new study that has shown that targeted treatment to areas of cancer inside a prostate previously treated for cancer using radiotherapy is effective and has … Continue reading Salvage focal ablative therapy for radio-recurrent prostate cancer is safe and provides good short to medium-term oncological control